chartexchange

NMRD
NEMAURA MEDICAL INC
stockOTC

EODOct 1, 2026
0.0001USD0.000%(0.00)3,700
Loading…
Loading…
Healthcare
Medical Devices
CEO
Dewan Chowdhury
HQ
New York, NY, USA
Previous Close
$0.00
Beta
193.86
52-Week High
$0.00 2026-04-29
52-Week Low
$0.00 2026-08-04
SMA 50
$0.00
SMA 200
$0.01
Avg. Vol 10D
2,423
Avg. Vol 30D
4,135
Avg. Vol 90D
6,498
Relative Vol
0.89
17.26M
Dec 5, 2019 · 1-for-10 (reverse)
NMRD Profile

nemaura medical inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. the company provides sugarbeat, a non-invasive continuous glucose monitoring device for use by persons with type i and type ii diabetes, as well as for screening pre-diabetic patients. it has a license agreement with healthimation, llc, which licenses the company to make, have made, use, offer to sell, sell, and import intensive medical diabetes and weight management program for type 2 diabetes, prediabetes, and general wellness; the why wait app; and common law trademarks which incorporate the mark why wait or whywait and the use of licensed marks. nemaura medical inc. was founded in 2009 and is based in new york, new york.

NMRD Performance
PeriodPriceDateChangeBeta
6M0.002026-04-06-50.00%1808.822
2Y0.022024-10-04-99.58%—
5Y5.942021-10-04-100.00%-3.462
NMRD Stock Summary

NEMAURA MEDICAL INC (OTC:NMRD) stock price today is $0.00, and today's volume is 3,700. NMRD is up 0.000% today. The 30 day average volume is 4,135. NMRD market cap is $4,035 with 40.35M shares outstanding.